Planet Innovation (PRIVATE.PLANETINNOVATION)

Overall impact
A (85)

Commentary

Planet Innovation is a leader for overall positive impact. With an 'A' rating of 85.4 for overall impact (97th percentile compared to all companies), Planet Innovation ranks 2nd out of 76 industry peers, behind Parexel International, and ahead of IMAC, Enzo Biochem, Invitae and 71 others. On top material causes for Planet Innovation's industry (Healthcare Software & Services), Planet Innovation performs well in Accountable Institutions (94.6 score), Child and Maternal Health (89.4), Accountable Institutions (81.3) and 9 other causes where it received an 'A' score. Planet Innovation did not receive a 'D' or 'F' rating on any cause.
Impact
Cause PRIVATE.PLANETINNOVATION
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2009
Employees
400
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Victoria, Australia
Share classes
PRIVATE.PLANETINNOVATION
Description
Provider of integrated manufacturing, product development and digital services with a focus on the biomedical, clean-tech and hi-tech industries. The company specializes in regulated biomedical products and hi-tech connected devices and provides an end-to-end offering of design, engineering, scientific, commercial, and manufacturing capabilities, enabling clients to develop and commercialize innovative products.
Material causes
Ethos considers the following causes material for Planet Innovation, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.